Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-24T01:22:41.941Z Has data issue: false hasContentIssue false
  • English
  • Français

Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines

Published online by Cambridge University Press:  15 May 2009

C. W. Potter ,
R. Jennings ,
K. Nicholson ,
D. A. J. Tyrrell  and
K. G. Dickinson
C. W. Potter
Affiliation:
Department of Virology, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX
R. Jennings
Affiliation:
Department of Virology, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX
K. Nicholson
Affiliation:
Division of Communicable Diseases, Medical Research Council, Clinical Research Centre, Watford Road, Harrow
D. A. J. Tyrrell
Affiliation:
Division of Communicable Diseases, Medical Research Council, Clinical Research Centre, Watford Road, Harrow
K. G. Dickinson
Affiliation:
Student Health Centre, University of Birmingham, Elms Road, North Campus, Birmingham B15 2SE
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Groups of student volunteers were immunized with one of five different inactivated influenza virus vaccines. The concentration of virus in the various vaccines differed by both the international unitage test and by the concentration of haemagglutinin, as measured by the single radial diffusion test; the results of the two methods of standardization showed no correlation. The serum HI response to immunization was variable; volunteers given A/England/72 showed a 16·6-fold increase in homologous serum antibody titre whilst volunteers given A/Hong Kong/68 vaccine showed a 4·2-fold increase. The variable response of volunteers to immunization could not be explained by the varied concentration of virus in the vaccines, as measured by either test, the titres of serum HI antibody present before immunization, or a combination of these two factors.

The ability to infect volunteers with WRL 105 virus 4 weeks after immunization with heterologous, inactivated virus vaccine was directly related to the degree of cross-reactivity between the haemagglutinins of this vaccine virus and WRL 105 virus. Thus, the greatest number of infections by the challenge virus were seen in volunteers given A/Hong Kong/68 vaccine, less were observed in volunteers given A/England/72 vaccine, and least were found in groups given A/Port Chalmers/73 or A/Scotland/74 vaccine. However, compared with the incidence of infection in volunteers given B/Hong Kong/73 vaccine, all the heterologous influenza A vaccine gave some immunity to challenge infection.

Type
Research Article
Information
Journal of Hygiene , Volume 79 , Issue 3 , December 1977 , pp. 321 - 332
Copyright
Copyright © Cambridge University Press 1977

References

REFERENCES

Aymard-Henry, M., Coleman, M. T., Dowdle, W. R., Laver, W. G. & Webster, R. G. (1973). Influenza virus neuraminidase and neuraminidase-inhibition test procedures. Bulletin of the World Health Organization 48, 199–202.Google ScholarPubMed
Beare, A. S., Hobson, D., Reed, S. E. & Tyrrell, D. A. J. (1968). A comparison of live and killed influenza virus vaccines. Lancet ii, 418–20.CrossRefGoogle Scholar
Bevan, A., Furminger, I. G. S. & Smith, C. H. (1975). Neuraminidase assay of influenza vaccines. Developments in Biological Standardization 28, 173–9.Google ScholarPubMed
Bradstreet, C. M. P. & Taylor, C. E. D. (1962). Technique of complement-fixation applicable to the diagnosis of virus diseases. Monthly Bulletin of the Ministry of Health and the Public Health Laboratory Service 21, 96–104.Google Scholar
Foy, H. M., Cooney, M. K. & McMahan, R. (1973). A/Hong Kong influenza immunity three years after immunization. Journal of the American Medical Association 226, 758–61.CrossRefGoogle ScholarPubMed
Foy, H. M., Cooney, M. K., McMahan, R., Bor, E. & Grayston, J. T. (1971). Single-dose monovalent A2/Hong Kong influenza vaccine. Journal of the American Medical Association 217, 1067–71.CrossRefGoogle ScholarPubMed
Freestone, D. S., Bowker, C. H., Letley, E., Ferris, R. D., White, W. G. & Barnes, G. M. (1976). A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination. Journal of Hygiene 76, 459–66.CrossRefGoogle ScholarPubMed
Haigh, W. & Howell, R. W. (1973). The efficiency of the A2/Aichi/68 strain in inhaled influenza immunization against A/England/42/72 variant. Journal of Social Occupational Medicine 23, 125–7.CrossRefGoogle Scholar
Hobson, D. (1975). Assessment of the efficiency of influenza vaccines against natural challenge. Developments in Biological Standardization 28, 285–94.Google ScholarPubMed
Hobson, D., Beare, A. S. & Ward-Gardner, A. (1972). Haemagglutination-inhibiting serum antibody titres as an index of response of volunteers to intranasal infection with live, attenuated strains of influenza virus. Proceedings of the Symposium on Live Influenza Vaccines, Zagreb 1971. pp. 73–84. Yugoslav Academy of Sciences and Arts.Google Scholar
Hoskins, T. W., Davies, J. R., Allchin, A., Miller, C. L. & PollocK, T. M. (1973). Controlled trial of inactivated influenza vaccine containing A/Hong Kong strain during an outbreak of influenza due to the A/England/42/72 strain. Lancet ii, 116–20.CrossRefGoogle Scholar
Meiklejohn, G., Kempe, C. H., Tahalman, W. G. & Lennette, E. H. (1952). Evaluation of monovalent influenza vaccines. Observations during an influenza A-prime epidemic. American Journal of Hygiene 55, 12–21.Google ScholarPubMed
Moffat, M. A. J., Stealey, V. M., Freestone, D. S. & MacDonald, A. (1976). Assessment of elicited antibody responses, clinical reactions and transmissibility of WRL 105 live influenza vaccine. Journal of Biological Standardization 4, 92–5.CrossRefGoogle ScholarPubMed
Morris, C. A., Freestone, D. S., Stealey, V. M. & Oliver, P. R. (1975). Recombinant WRL 105 strain live attenuated influenza vaccine. Lancet ii, 196–9.CrossRefGoogle Scholar
Pereira, M. S., Chakraverty, P., Schild, G. C., Coleman, M. T. & Dowdle, W. R. (1972). Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. British Medical Journal iv, 701–3.CrossRefGoogle Scholar
Potter, C. W. & Jennings, R. (1976). The hamster as a model for the study of influenza vaccines. Postgraduate Medical Journal 52, 345–51.CrossRefGoogle Scholar
Potter, C. W., Jennings, R., McLaren, C., Edey, D., Stuart-Harris, C. H. & Brady, M. (1975a). A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. Journal of Hygiene 75, 353–62.CrossRefGoogle Scholar
Potter, C. W., Jennings, R., McLaren, C. & Clark, A. (1975b). immune response of volunteers to intranasal inoculation with freeze-dried influenza A/Hong Kong/68 vaccine. Journal of Biological Standardization 3, 41–50.CrossRefGoogle Scholar
Potter, C. W., Jennings, R., Phair, J. P., Clark, A. & Stuart-Harris, C. H. (1977). Dose-response relationship to immunization with a new, surface-antigen-adsorbed influenza virus vaccine in volunteers. Journal of Infectious Diseases 135, 423–31.CrossRefGoogle ScholarPubMed
Ruben, F. L., Johnston, F. & Streiff, E. J. (1974). Immunity in a partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain. Journal of the American Medical Association 230, 863–6.CrossRefGoogle Scholar
Schild, G. C., Oxford, J. S., Dowdle, W. R., Coleman, M. T., Pereira, M. S. & Chakraverty, P. (1974). Antigenic variation in current influenza A viruses. Evidence of a high frequency of antigenic drift in the Hong Kong virus. Bulletin of the World Health Organization 51, 1–11.Google ScholarPubMed
Schild, G. C., Wood, J. M. & Newman, R. W. (1975). A single-radial-diffusion technique for the assay of influenza haemagglutinin antigen. Bulletin of the World Health Organization 52, 223–31.Google ScholarPubMed
Sever, J. L. (1962). Application of a microtechnique to viral serological investigations. Journal of Immunology 88, 320–9.CrossRefGoogle ScholarPubMed
Stiver, H. G., Graves, P., Eickhoff, T. C. & Meiklejohn, G. (1973). Efficacy of ‘Hong Kong’ vaccine in preventing ‘England’ variant influenza in 1972. New England Journal of Medicine 289, 1267–71.CrossRefGoogle ScholarPubMed
Stuart-Harris, C. H. & Schild, G. C. (1976). Influenza: The virus and the Disease. London: Edward Arnold.Google Scholar